Technology
Health
Medical

LeMaitre Vascular

$30.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.92 (-2.94%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell LMAT and other stocks, options, ETFs, and crypto commission-free!

About

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company focuses on the design, marketing, sales, service, and technical support of medical devices and implants for the treatment of peripheral vascular disease. Read More Its products include balloon catheters, carotid shunts, biologic patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. The company was founded by George D. LeMaitre on November 28, 1983 and is headquartered in Burlington, MA.

Employees
483
Headquarters
Burlington, Massachusetts
Founded
1983
Market Cap
594.73M
Price-Earnings Ratio
26.85
Dividend Yield
1.18
Average Volume
148.16K
High Today
$31.81
Low Today
$30.33
Open Price
$31.23
Volume
58.68K
52 Week High
$41.28
52 Week Low
$21.79

Collections

Technology
Health
Medical
Medical Devices
US
North America

News

Simply Wall StMar 17

At US$31.27, Is It Time To Put LeMaitre Vascular, Inc. (NASDAQ:LMAT) On Your Watch List?

LeMaitre Vascular, Inc. (NASDAQ:LMAT), which is in the medical equipment business, and is based in United States, led the NASDAQGM gainers with a relatively large price hike in the past couple of weeks. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock’s share price. However, what if the stock is still a bargain? Today I will analyse the most recent data on LeMaitre Vascular’s outlook and valuation to see if the opportunity still...

57
MarketBeatMar 10

Stock Price, News, & Analysis for LeMaitre Vascular

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. The company offers angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to temporarily perfuse the blood and other fluids into the vasculature. It also provides carotid s...

1
Simply Wall StFeb 28

Is LeMaitre Vascular, Inc.’s (NASDAQ:LMAT) CEO Salary Justified?

In 1992 George LeMaitre was appointed CEO of LeMaitre Vascular, Inc. (NASDAQ:LMAT). This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. Next, we’ll consider growth that the business demonstrates. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO. View our latest analysis fo...

28

Earnings

$0.17
$0.26
$0.34
$0.43
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected Apr 24, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.